Recent News

• 03.11.2025 - Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates
• 03.04.2025 - Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy
• 02.28.2025 - AI Meets Blood Monitoring: How This Innovative Blood Sensor Could Transform Patient Care
• 02.11.2025 - Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections
• 02.05.2025 - Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor
• 02.05.2025 - Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor
• 01.27.2025 - Inspira™ Introduces Advanced Features for INSPIRA™ ART100, Further Amplifying User and System Support

Recent Filings

• 03.11.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.11.2025 - EX-99.1 EX-99.1
• 03.10.2025 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 03.05.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.04.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.04.2025 - EX-99.1 EX-99.1
• 02.11.2025 - EX-99.1 EX-99.1
• 02.11.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 02.10.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 02.05.2025 - EX-99.1 EX-99.1